×
戻る Agenda
DA02: Current and Future Status of Drug Development in Japan, the US, and Europe under COVID-19 Pandemic
Session Chair(s)
E. Stewart Geary, MD
MD, Global Safety Officer, Eisai Co., Ltd., Japan
Junko Sato, PHD
Associate Executive Director, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Speaker(s)
Gerald Dal Pan, MD, MHS
Director, Office of Surveillance and Epidemiology, CDER, FDA, United States
Peter Honig, MD, MPH, FACP
, Advisor and Board Member, United States
Kiyohito Nakai, PHD
Chief Safety Officer, Pharmaceuticals and Medical Devices Agency (PMDA), Japan